GleamWall
中文EN

RAJAF TFA Therapeutics, Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1885680 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-0.6%
TTM net income YoY31.6%
TTM EPS YoY—
Revenue 3-yr CAGR185.9%
Net income 3-yr CAGR—

Margins

Gross margin61.1%
Operating margin-11.3%
Net margin-12.4%
FCF margin—
EBITDA margin-0.5%

Returns

ROE—
ROA-3.3%
ROIC (approx.)—
Asset turnover0.27x

Leverage & solvency

Liabilities / assets111.5%
Debt / equity—
Current ratio0.19x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.23x
Accruals ratio-2.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2023Q4*2023-12-312022Q4*2022-12-31
Income statement
Revenue$315,502—
Cost of revenue$30,842—
Gross profit$284,660—
SG&A expense$350,152$317,681
Operating income$117,999-$264,482
Interest expense$22,007$71,772
Pretax income$91,930-$36,891
Net income$973,422-$77,046
EBITDA$173,716-$107,828
EPS (diluted)——
Balance sheet
Cash & equivalents$23,104$6,628
Receivables—$149,510
Inventory—$313,530
Current assets$327,175$501,552
PP&E, net$2.81M$75,510
Total assets$3.35M$2.10M
Current liabilities$2.97M$2.52M
Short-term debt—$57,109
Long-term debt$431,079$414,000
Total debt$431,079$471,109
Total liabilities$3.50M$3.06M
Shareholders' equity-$151,796-$951,334
Net debt$407,975$464,481
Shares outstanding111.12M111.12M
Cash flow statement
Operating cash flow-$1.23M-$110,817
Capital expenditure-$1.33M—
Free cash flow$101,453—
Investing cash flow$1.22M-$1,456
Financing cash flow$48,030$6,970
Depreciation & amortization$55,717$156,654

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.